ALLO – allogene therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ALLO

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

6/23

09:04 pm

allo

Form 4 Allogene Therapeutics, For: Jun 18 Filed by: SATO VICKI L

Low Report

Form 4 Allogene Therapeutics, For: Jun 18 Filed by: SATO VICKI L

Report

6/23

09:04 pm

allo

Form 4 Allogene Therapeutics, For: Jun 18 Filed by: Barrett Elizabeth A.

Low Report

Form 4 Allogene Therapeutics, For: Jun 18 Filed by: Barrett Elizabeth A.

Report

6/23

09:04 pm

allo

Form 4 Allogene Therapeutics, For: Jun 18 Filed by: Humer Franz B

Low Report

Form 4 Allogene Therapeutics, For: Jun 18 Filed by: Humer Franz B

Report

6/23

09:04 pm

allo

Form 4 Allogene Therapeutics, For: Jun 18 Filed by: MESSEMER DEBORAH M.

Low Report

Form 4 Allogene Therapeutics, For: Jun 18 Filed by: MESSEMER DEBORAH M.

Report

6/23

09:03 pm

allo

Form 4 Allogene Therapeutics, For: Jun 18 Filed by: Kazam Joshua A

Low Report

Form 4 Allogene Therapeutics, For: Jun 18 Filed by: Kazam Joshua A

Report

6/23

09:03 pm

allo

Form 4 Allogene Therapeutics, For: Jun 18 Filed by: Mayo Stephen

Low Report

Form 4 Allogene Therapeutics, For: Jun 18 Filed by: Mayo Stephen

Report

6/23

09:03 pm

allo

Form 4 Allogene Therapeutics, For: Jun 18 Filed by: WITTE OWEN N.

Low Report

Form 4 Allogene Therapeutics, For: Jun 18 Filed by: WITTE OWEN N.

Report

6/23

04:28 pm

allo

Form 8-K Allogene Therapeutics, For: Jun 18

Low Report

Form 8-K Allogene Therapeutics, For: Jun 18

Report

6/12

04:18 pm

allo

Form 4 Allogene Therapeutics, For: Jun 10 Filed by: MESSEMER DEBORAH M.

Low Report

Form 4 Allogene Therapeutics, For: Jun 10 Filed by: MESSEMER DEBORAH M.

Report

6/10

04:29 pm

allo

Form 144 Allogene Therapeutics, Filed by: MESSEMER DEBORAH M.

Low Report

Form 144 Allogene Therapeutics, Filed by: MESSEMER DEBORAH M.

Report

5/13

04:08 pm

allo

Form 10-Q Allogene Therapeutics, For: Mar 31

High Report

Form 10-Q Allogene Therapeutics, For: Mar 31

Report

5/13

04:07 pm

allo

Form 8-K Allogene Therapeutics, For: May 13

High Report

Form 8-K Allogene Therapeutics, For: May 13

Report

5/13

11:44 am

allo

Form SCHEDULE 13G Allogene Therapeutics, Filed by: Capital World Investors

Medium Report

Form SCHEDULE 13G Allogene Therapeutics, Filed by: Capital World Investors

Report

5/9

05:49 pm

allo

Form SCHEDULE 13G/A Allogene Therapeutics, Filed by: Chang David D

Medium Report

Form SCHEDULE 13G/A Allogene Therapeutics, Filed by: Chang David D

Report

5/9

05:31 pm

allo

Form SCHEDULE 13G/A Allogene Therapeutics, Filed by: Belldegrun Arie

Medium Report

Form SCHEDULE 13G/A Allogene Therapeutics, Filed by: Belldegrun Arie

Report

4/30

06:02 am

allo

Form DEFA14A Allogene Therapeutics,

Medium Report

Form DEFA14A Allogene Therapeutics,

Report

4/30

06:02 am

allo

Form ARS Allogene Therapeutics, For: Dec 31

Medium Report

Form ARS Allogene Therapeutics, For: Dec 31

Report

4/30

06:02 am

allo

Form DEF 14A Allogene Therapeutics, For: Jun 18

Medium Report

Form DEF 14A Allogene Therapeutics, For: Jun 18

Report

4/23

05:29 pm

allo

Form 4 Allogene Therapeutics, For: Apr 21 Filed by: Yoshiyama Annie

Medium Report

Form 4 Allogene Therapeutics, For: Apr 21 Filed by: Yoshiyama Annie

Report

4/21

04:50 pm

allo

Form 144 Allogene Therapeutics, Filed by: Yoshiyama Annie

High Report

Form 144 Allogene Therapeutics, Filed by: Yoshiyama Annie

Report

4/17

09:37 am

allo

Form SCHEDULE 13G/A Allogene Therapeutics, Filed by: BlackRock, Inc.

Low Report

Form SCHEDULE 13G/A Allogene Therapeutics, Filed by: BlackRock, Inc.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.